Home > Insider Trading > Filing (0001209191-16-126265)

Filing Details

Accession Number:: 0001209191-16-126265
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-07 16:41:07
Reporting Period:: 2016-06-07

Filing Date:: 2016-06-07
Accepted Time:: 2016-06-07 16:41:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1539029	Clearside Biomedical Inc.	CLSD	Pharmaceutical Preparations (2834)	452437375

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1664697	H. Daniel White	C/O Clearside Biomedical, Inc. 1220 Old Alpharetta Road, Suite 300 Alpharetta GA 30005	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-06-07	66,518	$0.00	530,163	No	4	C	Direct
Common Stock	Acquisiton	2016-06-07	657	$0.02	530,820	No	4	X	Direct
Common Stock	Disposition	2016-06-07	3	$7.00	530,817	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	X	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2016-06-07	133,234	$0.00	60,560	$0.00
Common Stock	Series B Preferred Stock	Disposition	2016-06-07	13,110	$0.00	5,958	$0.00
Common Stock	Warrant to Purchase Common Stock (right to buy)	Disposition	2016-06-07	657	$0.00	657	$0.02

Exercise Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	No	4	C	Direct
	No	4	C	Direct
2014-04-28	No	4	X	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	40,909	Indirect	By White Family Trust
Common Stock	301	Indirect	As UTMA custodian for son
Common Stock	844	Indirect	As UTMA custodian for son
Common Stock	1,188	Indirect	As UTMA custodian for son

Footnotes

Represents shares received upon conversion of shares of Series A Preferred Stock and Series B Preferred Stock.
Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.454545 shares of the Issuer's common stock. The Preferred Stock had no expiration date.
On June 7, 2016, the reporting person exercised a warrant to purchase 657 shares of Issuer's common stock for $0.022 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 3 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 654 shares.
These securities are held in trust for the benefit of the reporting person's children. The reporting person's wife serves as trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These securities are held for the benefit of the reporting person's son under the Georgia Uniform Transfers to Minors Act, for which the reporting person serves as custodian. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
This warrant would have expired upon the closing of the Issuer's initial public offering.